These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1588567)

  • 21. Determination of dissociation constants and relative efficacies of some muscarinic agonists at nicotinic receptors.
    Lucchelli A; Boselli C; Grana E
    Farmaco Sci; 1987 Sep; 42(9):619-27. PubMed ID: 3691787
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activities of 5-methylfurfuryltrimethylammonium iodide and related compounds at vascular endothelial muscarinic receptors of the rat aorta.
    Horst MA; Sastry BV; Landon EJ
    Arch Int Pharmacodyn Ther; 1987 Jul; 288(1):87-99. PubMed ID: 3662700
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological activity of 1,2,4-oxadiazole derivatives: highly potent and efficacious agonists for cortical muscarinic receptors.
    Street LJ; Baker R; Book T; Kneen CO; MacLeod AM; Merchant KJ; Showell GA; Saunders J; Herbert RH; Freedman SB
    J Med Chem; 1990 Oct; 33(10):2690-7. PubMed ID: 2213823
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eudismic analysis of a series of muscarinic ligands carrying a 1,3-oxathiolane nucleus.
    Gualtieri F; Romanelli MN; Teodori E
    Chirality; 1990; 2(2):79-84. PubMed ID: 2400641
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical and biochemical studies of 2-propynylpyrrolidine derivatives. Restricted-rotation analogues of N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5).
    Trybulski EJ; Kramss RH; Mangano RM; Rusinko A
    J Med Chem; 1990 Dec; 33(12):3190-8. PubMed ID: 2258905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Discriminative stimulus properties of the muscarinic receptor agonists Lu 26-046 and O-Me-THPO in rats: evidence for involvement of different muscarinic receptor subtypes.
    Arnt J; Lembøl HL; Meier E; Pedersen H
    Eur J Pharmacol; 1992 Jul; 218(1):159-69. PubMed ID: 1397027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat.
    Hammer R; Giraldo E; Schiavi GB; Monferini E; Ladinsky H
    Life Sci; 1986 May; 38(18):1653-62. PubMed ID: 3754610
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Affinities of different cholinergic agonists for the high and low affinity states of hippocampal M1 muscarine receptors.
    Potter LT; Ferrendelli CA
    J Pharmacol Exp Ther; 1989 Mar; 248(3):974-8. PubMed ID: 2539465
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular requirements of the active sites of the cholinergic receptors. XVI - Synthesis and cholinergic activity of 2- or 5-alkyl or 5-phenyl-4-methyl-3-oxo-1-dimethylaminomethylcyclopentane methiodide.
    Pigini M; Brasili L
    Farmaco Sci; 1981 Feb; 36(2):152-8. PubMed ID: 7227502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Himbacine discriminates between putative muscarinic M1 receptor-mediated responses.
    Sagrada A; Duranti P; Giudici L; Schiavone A
    Life Sci; 1994; 54(17):PL305-10. PubMed ID: 7513038
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [3H]pirenzepine and (-)-[3H]quinuclidinyl benzilate binding to rat cerebral cortical and cardiac muscarinic cholinergic sites. I. Characterization and regulation of agonist binding to putative muscarinic subtypes.
    Watson M; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1986 May; 237(2):411-8. PubMed ID: 3754580
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of cevimeline on excitability of parasympathetic preganglionic neurons in the superior salivatory nucleus of rats.
    Mitoh Y; Ueda H; Ichikawa H; Fujita M; Kobashi M; Matsuo R
    Auton Neurosci; 2017 Sep; 206():1-7. PubMed ID: 28600120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the in vitro and in vivo profiles of tolterodine with those of subtype-selective muscarinic receptor antagonists.
    Gillberg PG; Sundquist S; Nilvebrant L
    Eur J Pharmacol; 1998 May; 349(2-3):285-92. PubMed ID: 9671109
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, and neurochemical evaluation of 2-amino-5-(alkoxycarbonyl)-3,4,5,6-tetrahydropyridines and 2-amino-5-(alkoxycarbonyl)-1,4,5,6-tetrahydropyrimidines as M1 muscarinic receptor agonists.
    Dunbar PG; Durant GJ; Rho T; Ojo B; Huzl JJ; Smith DA; el-Assadi AA; Sbeih S; Ngur DO; Periyasamy S
    J Med Chem; 1994 Aug; 37(17):2774-82. PubMed ID: 8064804
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel functional M1 selective muscarinic agonists. 2. Synthesis and structure-activity relationships of 3-pyrazinyl-1,2,5,6-tetrahydro-1-methylpyridines. Construction of a molecular model for the M1 pharmacophore.
    Ward JS; Merritt L; Klimkowski VJ; Lamb ML; Mitch CH; Bymaster FP; Sawyer B; Shannon HE; Olesen PH; Honoré T
    J Med Chem; 1992 Oct; 35(22):4011-9. PubMed ID: 1433209
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro muscarinic activity of spiromuscarones and related analogs.
    Wu ES; Griffith RC; Loch JT; Kover A; Murray RJ; Mullen GB; Blosser JC; Machulskis AC; McCreedy SA
    J Med Chem; 1995 Apr; 38(9):1558-70. PubMed ID: 7739014
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The design of full agonists for the cortical muscarinic receptor.
    Saunders J; Freedman SB
    Trends Pharmacol Sci; 1989 Dec; Suppl():70-5. PubMed ID: 2694527
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6beta-Acyloxy(nor)tropanes: affinities for antagonist/agonist binding sites on transfected and native muscarinic receptors.
    Daly JW; Gupta TH; Padgett WL; Pei XF
    J Med Chem; 2000 Jun; 43(13):2514-22. PubMed ID: 10891110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PC12 phaeochromocytoma cells contain an atypical muscarinic receptor binding site.
    Michel AD; Stefanich E; Whiting RL
    Br J Pharmacol; 1989 Jul; 97(3):914-20. PubMed ID: 2758243
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
    Vickroy TW; Roeske WR; Yamamura HI
    J Pharmacol Exp Ther; 1984 Jun; 229(3):747-55. PubMed ID: 6202869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.